Henry: Cancer Management in Small Animal Practice

Chapter 18: Supportive Care of the Cancer Patient

References

Section A: Prevention and Management of Nausea and Vomiting

  1. Coates A, Abraham S, Kaye SB, et al: On the receiving end—patient perception of the side effects of cancer chemotherapy, Eur J Cancer Clin Oncol 19(2):203, 1983. Medline abstracts
  2. Lindley CM, Bernard S, Fields SM: Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population, J Clin Oncol 7(8):1142, 1989. Medline abstracts
  3. Berger AM, Clark-Snow RA: Adverse effects of treatment. In DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: principles and practice of oncology, ed 7. Philadelphia, 2005, Lippincott, Williams & Wilkins, p 2515.
  4. Olver IN: Update on antiemetics for chemotherapy-induced emesis, Int Med J 35:478, 2005. Medline abstracts
  5. Twedt DC: Vomiting. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine, ed 6. St Louis, 2005, Elsevier/Saunders, p 132.
  6. Washabau RJ, Elie MS: Antiemetic therapy. In Bonagura JD (ed): Kirk’s current veterinary therapy XII: small animal practice. Philadelphia, 1995, WB Saunders, p 679.
  7. Miller AD, Leslie RA: The area postrema and vomiting, Front Neuroendocrinol 15(4):301, 1994. Medline abstracts
  8. Hesketh PJ, Van Belle S, Aapro M, et al: Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists, Eur J Cancer 39(8):1074, 2003. Medline abstracts
  9. Puente-Redondo VA, Siedek EM, Benchaoui HA, et al: The antiemetic efficacy of maropitant (CereniaTM) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe, J Small Anim Pract 48(2):93, 2007. Medline abstracts
  10. Vail DM, Rodabaugh HS, Conder GA, et al: Efficacy of injectable maropitant (Cerenia) in a randomized clinical trial for prevention and treatment of cisplatin-induced emesis in dogs presented as veterinary patients, Vet Comp Onc 5(1):38, 2007. Medline abstracts
  11. Puente-Redondo VA, Tilt N, Rowan TM, et al: Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs, Am J Vet Res 68(1):48, 2007. Medline abstracts
  12. Moore AS, Rand WM, Berg J, et al: Evaluation of butorphanol and cyproheptadine for prevention of cisplatin-induced vomiting in dogs, J Am Vet Med Assoc 205(3):441, 1995.
  13. Moore AS, Nelson RW, Henry CJ, et al: Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999), J Am Vet Med Assoc 221(6):811, 2002. Medline abstracts

Section B: Nutritional Management of the Cancer Patient

  1. Michel KE, Sorenmo K, Shofer FS: Evaluation of body condition and weight loss in dogs presented to a veterinary oncology service, J Vet Intern Med 18:692, 2004. Medline abstracts
  2. Persson C, Glimelius B: The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy, Anticancer Res 22:3661, 2002. Medline abstracts
  3. Van Cutsem E, Arends J: The causes and consequences of cancer-associated malnutrition, Eur J Oncol Nurs 9(Suppl 2):S51, 2005.
  4. Nguyen TV, Yueh B: Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas, Cancer 95:553, 2002. Medline abstracts
  5. Deans C, Wigmore SJ: Systemic inflammation, cachexia and prognosis in patients with cancer, Curr Opin Clin Nutr Metab Care 8:265, 2005. Medline abstracts
  6. Fearon KC, Voss AC, Hustead DS: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis, Am J Clin Nutr 83:1345, 2006. Medline abstracts
  7. Arai T, Ogino T, Gunji M, et al: Changes in glucose transport activities in mammary adenocarcinoma of dogs, Res Vet Sci 62:85, 1997. Medline abstracts
  8. Mazzaferro EM, Hackett TB, Stein TP, et al: Metabolic alterations in dogs with osteosarcoma, Am J Vet Res 62:1234, 2001. Medline abstracts
  9. Ogilvie GK, Ford RB, Vail DM, et al: Alterations in lipoprotein profiles in dogs with lymphoma, J Vet Intern Med 8:62, 1994. Medline abstracts
  10. Ogilvie GK, Walters L, Salman MD, et al: Alterations in carbohydrate metabolism in dogs with nonhematopoietic malignancies, Am J Vet Res 58:277, 1997. Medline abstracts
  11. Vail DM, Ogilvie GK, Fettman MJ, et al: Exacerbation of hyperlactatemia by infusion of lactated ringer’s solution in dogs with lymphoma, J Vet Intern Med 4:228, 1990. Medline abstracts
  12. Vail DM, Ogilvie GK, Wheeler SL, et al: Alterations in carbohydrate metabolism in canine lymphoma, J Vet Intern Med 4:8, 1990. Medline abstracts
  13. Ogilvie GK, Vail DM, Wheeler SL, et al: Effects of chemotherapy and remission on carbohydrate metabolism in dogs with lymphoma, Cancer 69:233, 1992. Medline abstracts
  14. Ogilvie GK, Vail DM, Wheeler SL: Alterations in fat and protein metabolism in dogs with cancer (abstract), Proc Vet Cancer Society 31, 1988.
  15. Tachibana K, Mukai K, Hiraoka I, et al: Evaluation of the effect of arginine-enriched amino acid solution on tumor growth, J Parenter Enteral Nutr 9:428, 1985. Medline abstracts
  16. Ye SL, Istfan NW, Driscoll DF, et al: Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition, Cancer 69:261, 1992. Medline abstracts
  17. Anderson CR, Ogilvie GK, Fettman MJ, et al: Effect of fish oil and arginine on acute effects of radiation injury in dogs with nasal tumors: a double-blind randomized study (abstract), Proc Vet Cancer Society 33, 1997.
  18. Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al: Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study, Cancer 88:1916, 2000. Medline abstracts
  19. Roudebush P, Davenport DJ, Novotny BJ: The use of nutraceuticals in cancer therapy, Vet Clin North Am (Small Anim Pract) 34:249, 2004. Medline abstracts
  20. Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al: Effect of fish oil, arginine and doxorubicin chemotherapy on remission and survival time in dogs with lymphoma: a double blind, randomized placebo controlled study (abstract), J Vet Intern Med 14:389, 2000.
  21. Thatcher CD, Hand MS, Remillard RL: Small animal clinical nutrition: an interactive process. In Thatcher CD, Hand MS, Remillard RL, et al (eds): Small animal clinical nutrition. Topeka, 2010, Mark Morris Institute, pp 2-22.
  22. Remillard RL, Crane SW, et al: Making pet foods at home. In Thatcher CD, Hand MS,  Remillard RL, et al (eds): Small animal clinical nutrition, Topeka, 2010, Mark Morris Institute, pp 201-224.
  23. Weese JS, Rousseau J, Arroyo L: Bacteriological evaluation of commercial canine and feline raw diets, Can Vet J 46:513, 2005. Medline abstracts
  24. Strohmeyer RA, Morley PS, Hyatt DR, et al: Evaluation of bacterial and protozoal contamination of commercially available raw meat diets for dogs, J Am Vet Med Assoc 228:537, 2006. Medline abstracts
  25. Saker KE, Selter KA: Cancer. In Thatcher CD, Hand MS, Remillard RL, et al (eds): Small animal clinical nutrition. Topeka, 2010, Mark Morris Institute, pp 587-608.
  26. Plumb DC: Plumb’s veterinary drug handbook, ed 6. Ames, IA, 2008, Blackwell Publishing, pp 623-625.
  27. Saker KE, Remillard RL: Critical care nutrition and enteral-assisted feeding. In Thatcher CD, Hand MS, Remillard RL, et al (eds): Small animal clinical nutrition. Topeka, 2010, Mark Morris Institute, pp 439-476.
  28. Ogilvie GK: Alterations in metabolism and nutritional support for veterinary cancer patients: recent advances, Compend Contin Educ Pract Vet 15:925, 1993.
  29. Marks SL: Nasoesophageal, esophagostomy, and gastrostomy tube placement techniques. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine, ed 6. St Louis, 2005, Saunders/Elsevier, pp 329-336.
  30. Mauldin GE: Nutritional support of the cancer patient. In Bonagura JD (ed): Kirk’s current veterinary therapy (small animal practice) XIII. Philadelphia, 2000, WB Saunders, pp 458-462.
  31. McNiel EA, Ogilvie GK, Mallinckrodt C, et al: Platelet function in dogs treated for lymphoma and hemangiosarcoma and supplemented with dietary n-3 fatty acids, J Vet Intern Med 13:574, 1999. Medline abstracts
  32. Myers NC, Gross KL, Armstead EA, et al: The effect of dietary n-6:n-3 fatty acid ratio on hemostatic parameters and platelet aggregation in the dog (abstract), Proc Am Coll Vet Intern Med 753, 1996.
  33. Bright JM, Sullivan PS, Melton SL, et al: The effects of n-3 fatty acid supplementation on bleeding time, plasma fatty acid composition and in vitro platelet aggregation in cats, J Vet Intern Med 8:247, 1994. Medline abstracts
  34. Sullivan P, Bright J: Role of n-3 fatty acid supplementation for the prevention of thrombosis in cats with cardiovascular disease (abstract), Proc Am Coll Vet Intern Med pp 482-483, 1995.
  35. Saker KE, Eddy AL, Thatcher CD, et al: Manipulation of dietary (n-6) and (n-3) fatty acids alters platelet function in cats, J Nutr 128(12 Suppl):2645S, 1998. Medline abstracts

Section C: Assessment and Management of Pain in the Cancer Patient

  1. Foley KM: Management of cancer pain. In DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: principles and practice of oncology, ed 6. Philadelphia, 2001, Lippincott, Williams & Wilkins, pp 2977-3011.
  2. Bruera ED, Portenoy RK (eds): Cancer pain: assessment and management. Cambridge, 2003, Cambridge University Press, p 485.
  3. Lascelles BD: Management of chronic cancer pain. In Withrow SJ, Vail DM (eds): Withrow and MacEwen`s small animal clinical oncology, ed 4. St Louis, 2007, Saunders/Elsevier, pp 291-306.
  4. Gaynor JS, Muir WW: Handbook of veterinary pain management, ed 2. St Louis, 2008, Mosby/Elsevier.
  5. Kyles AE, Ruslander D: Chronic pain: osteoarthritis and cancer, Semin Vet Med Surg (Small Anim) 12:122, 1997. Medline abstracts
  6. Lascelles BD: Relief of chronic cancer pain. In Dobson J, Lascelles BD (eds): BSAVA manual of oncology, ed 2. Cheltenham, UK, 2003, BSAVA Publications, pp 137-151.
  7. de Lorimier LP, Fan TM: Understanding and recognizing cancer pain in dogs and cats, Vet Med 100(5):352, 2005.
  8. Slavin KV, Tesoro EP, Mucksavage JJ: The treatment of cancer pain, Drugs Today 40:235, 2004. Medline abstracts
  9. de Lorimier LP, Fan TM: Treating cancer pain in dogs and cats, Vet Med 100(5):365, 2005.
  10. Robertson SA, Lascelles BD, Taylor PM, et al: PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration, J Vet Pharmacol Ther 28:453, 2005. Medline abstracts
  11. Lascelles BD, Robertson SA: Use of thermal threshold response to evaluate the antinociceptive effects of butorphanol in cats, Am J Vet Res 65:1085, 2004. Medline abstracts
  12. Leppert W, Luczak J: The role of tramadol in cancer pain treatment—a review, Support Care Cancer 13:5, 2005. Medline abstracts
  13. Kukanich B, Papich MG: Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs, J Vet Pharmacol Ther 27:239, 2004. Medline abstracts
  14. Lascelles BD, Gaynor JS, Smith ES, et al: Amantadine in a multimodal analgesic regimen for alleviation of refractory osteoarthritis pain in dogs, J Vet Intern Med 22:53, 2008. Medline abstracts
  15. Lamont LA: Adjunctive analgesic therapy in veterinary medicine, Vet Clin North Am Small Anim Pract 38:1187, 2008. Medline abstracts
  16. Chew DJ, Buffington CA, Kendall MS, et al: Amitriptyline treatment for severe recurrent idiopathic cystitis in cats, J Am Vet Med Assoc 213:1282, 1998. Medline abstracts
  17. Fan TM, de Lorimier LP, Charney SC, et al: Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement, J Vet Intern Med 19:74, 2005. Medline abstracts
  18. Milner RJ, Farese J, Henry CJ, et al: Bisphosphonates and cancer, J Vet Intern Med 18:597, 2004. Medline abstracts
  19. Fan TM, de Lorimier LP, Garrett LD, et al: The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis, J Vet Intern Med 22:380, 2008. Medline abstracts
  20. Wypij JM, Fan TM, Fredrickson RL, et al: In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats, J Vet Intern Med 22:158, 2008. Medline abstracts
  21. Fan TM, de Lorimier LP, O’Dell-Anderson K, et al: Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain, J Vet Intern Med 21:431, 2007. Medline abstracts
  22. Alimi D, Rubino C, Pichard-Léandri E, et al: Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial, J Clin Oncol 21:4120, 2003. Medline abstracts
  23. Deng G, Cassileth BR, Yeung KS: Complementary therapies for cancer-related symptoms, J Support Oncol 2:419, 2004. Medline abstracts

Section D: Palliative Care for the Cancer Patient

  1. World Health Organization: National cancer control programmes: policies and managerial guidelines, ed 2. Geneva, 2002a, World Health Organization.
  2. Mellanby RJ, Herrtage ME, Dobson JM: Owners’ assessment of their dog’s quality of life during palliative chemotherapy for lymphoma, J Small Anim Pract 44:100, 2003. Medline abstracts
  3. Wojciechowska JI, Hewson CJ: Quality-of-life assessment in pet dogs, J Am Vet Med Assoc 226:722, 2005. Medline abstracts
  4. Mayer MN, Grier CK: Palliative radiation therapy for canine osteosarcoma, Can Vet J 47:707, 2006. Medline abstracts
  5. World Health Organization: Cancer pain relief, with a guide to opioid availability, ed 2. Geneva, 1996, World Health Organization.
  6. Weisse C, Berent A, Todd K, et al: Evaluation of palliative stenting for management of malignant urethral obstructions in dogs, J Am Vet Med Assoc 229:226, 2006. Medline abstracts